Nektar Therapeutics (NKTR) Stock: Buy, Sell, or Hold?
$38.44
+0.66 (+1.75%)
▲
5d:
-0.1%
30d:
+1.37%
90d:
-49.37%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (74%)
Quality Score
55/100
Position
FAIR
30-Day Fair Range
$36.91 – $39.89
Position: FAIR
Forward P/E & Valuation
-3.7x
Next 12M consensus est.
Wall Street Target
$133.08
+246.2% upside
Options IV & Volume
54th pct IV
HIGH volume confirmation
Support / Resistance
$35.76 / $39.89
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: NKTR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When NKTR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NKTR is currently trading at $38.44, which is considered fair relative to its 30-day fair value range of $36.91 to $39.89.
Technical Outlook: Technically, NKTR is in a strong uptrend. Immediate support is located at $35.76, while resistance sits at $39.89.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $133.08 (+246.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NKTR is in a strong uptrend. Immediate support is located at $35.76, while resistance sits at $39.89.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $133.08 (+246.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$36.91 -
$39.89
Company Quality Score
55/100
(HOLD)
Options IV Signal
54th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
73.8%
Trading Range & Key Levels
30-Day Trading Range
$36.91 -
$39.89
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$4.25
(11.1%)
Support Level
$35.76
Resistance Level
$39.89
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 54th percentile)
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 246.2% below Wall St target ($133.08)
- NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-3.66
Wall Street Target
$133.08
(+246.2%)
Revenue Growth (YoY)
-9.3%
Profit Margin
-287.8%
Share NKTR Analysis
Share this live NKTR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NKTR)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 5, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user expressed their confidence in investing in $NKTR, despite the lack of recent news articles.
Key Retail Themes:
Buy the dip
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:53 AM ET
Data refreshes hourly during market hours. Next update: 3:53 AM
Data refreshes hourly during market hours. Next update: 3:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NKTR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 52 HOLD |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 33 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NKTR Research Pages
